PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

Clinical trial NCT04745949 · RECRUITING

Trial details

NCT number: NCT04745949
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Lymphoma

Start date: 2021-05-10
Primary completion: 2027-08-03
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.